SCHEMBL4279434

SCHEMBL4279434

CC1=C(C)c2cc3ccccc3cc2C(=O)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 0.43
▸ MAOB P27338 1/20 0.43
▸ ELANE P08246 1/20 0.42
▸ ILF3 Q12906 1/20 0.40
▸ GAPDH P04406 1/20 0.40
▸ PTGS2 P35354 1/20 0.39
▸ PTPRC P08575 3/20 0.39
▸ S100A4 P26447 3/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ CES2 O00748 2/20 0.39
▸ BCHE P06276 2/20 0.39
▸ CES1 P23141 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ APAF1 O14727 2/20 0.39
▸ TDP2 O95551 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ PLA2G1B P04054 2/20 0.39
▸ POLB P06746 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8802648 0.93 MAOA (0.50) MAOAMAOBELANEILF3GAPDH
SCHEMBL11051134 0.89 MAOA (0.54) MAOAMAOBELANEILF3GAPDH
SCHEMBL27916612 0.84 MAOA (0.50) MAOAMAOBELANEILF3GAPDH
SCHEMBL27935063 0.84 MAOA (0.50) MAOAMAOBELANEILF3GAPDH
SCHEMBL19230417 0.81 ALDH1A1 (0.52) MAOAILF3GAPDHPTGS2PTPRC
SCHEMBL29364188 0.78 MEN1 (0.56) MAOAELANEILF3GAPDHPTGS2
SCHEMBL30130196 0.78 MEN1 (0.56) MAOAELANEILF3GAPDHPTGS2
SCHEMBL354514 0.78 MEN1 (0.56) MAOAELANEILF3GAPDHPTGS2
SCHEMBL9429592 0.77 ELANE (0.50) ELANEILF3GAPDHPTGS2NPC1
SCHEMBL8586117 0.77 S100A4 (0.60) MAOAMAOBELANEPTPRCS100A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109310604-A Use of specific compounds for modifying, reducing or eliminating off-flavours 西姆莱斯有限公司 2019-02-05 — — CN disclosed
CN-102376899-B Luminescent device and display device 株式会社理光 2016-06-22 — — CN disclosed
CN-102376899-A Light emitting device and display unit RICOH CO LTD 2012-03-14 — — CN disclosed
US-20090143279-A1 Methods and compositions for treating metabolic disorders PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2009-06-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143279-A1 Methods and compositions for treating metabolic disorders PC, PCK2, CS MAOA 798/4885MAOB 704/4885ELANE 3226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback